prescription drugs; advertising; requirements
HB 2199 requires that advertisements for prescription and nonprescription drugs on TV, radio, or online must clearly present major side effects and usage restrictions ("major statement") at the same volume, clarity, and pace as the rest of the ad. It prohibits using distracting audio or visual elements that could interfere with understanding these critical health details. The bill directly affects drug manufacturers and advertisers operating in Arizona. If passed, it would mandate that health risks are communicated as prominently as promotional content in digital and broadcast ads.
Bill status
introduced
1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 21, 2025
Last action Jan 22, 2025
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
2
Key actions
0
Committee
0
1 primary · 17 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Nick Kupper
RRepublican
Co
Beverly Pingerelli
RRepublican
Co
Cesar Aguilar
DDemocratic
Co
Chris Lopez
RRepublican
Co
David Marshall
RRepublican
Co
John Gillette
RRepublican
Co
Julie Willoughby
RRepublican
Co
Justin Wilmeth
RRepublican
Co
Leo Biasiucci
RRepublican
Co
Lisa Fink
RRepublican
Co
Lupe Diaz
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 2199
Scope: AZ
Hi! I can help you understand HB 2199. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline